Cardiovascular dysfunction caused by cecal ligation and puncture is attenuated in CD8 knockout mice treated with anti-asialoGM1.
The present study was designed to assess hemodynamics and myocardial function at 18 h after injury caused by cecal ligation and puncture (CLP) in CD8-knockout mice treated with anti-asialoGM1 (CD8KO/alphaAsGM1 mice). Arterial pressure was measured by carotid artery cannulation, and left ventricular pressure-volume measurements were obtained by use of a 1.4-Fr conductance catheter. Blood acid-base balance and indexes of hepatic, renal, and pulmonary injury were also measured. CD8KO/alphaAsGM1 mice exhibited higher mean arterial pressure and increased systemic vascular resistance compared with wild-type mice. Cardiac output was significantly decreased in wild-type, but not CD8KO/alphaAsGM1, mice compared with sham controls. Myocardial function was better preserved in CD8KO/alphaAsGM1 mice as indicated by less impairment of left ventricular pressure development over time, time varying maximum elastance, end-systolic pressure-volume relationship, and preload recruitable stroke work. The impairment in myocardial function was associated with induction of proinflammatory cytokine mRNAs in the hearts of wild-type mice. The hemodynamic derangements in wild-type mice were coupled with significant metabolic acidosis and elevated serum creatinine levels. Overall, this study shows that cardiovascular collapse and shock characterized by hypotension, myocardial depression, low systemic vascular resistance, and metabolic acidosis occurs after CLP in wild-type mice but is attenuated in CD8KO/alphaAsGM1 mice. These observations likely explain, in part, the previously observed survival advantage of CD8KO/alphaAsGM1 mice following CLP.
Tao
Weike
W
Dept. of Anesthesiology, The University of Texas Medical Branch, Galveston, TX 77555-0591, USA.
Enoh
Victor T
VT
Lin
Cheng Y
CY
Johnston
William E
WE
Li
Peng
P
Sherwood
Edward R
ER
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D016827:CD8 Antigens / Q000235:genetics / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000503:physiopathology*; D002432:Cecum; D016207:Cytokines / Q000378:metabolism; D005260:Female; D005677:G(M1) Ganglioside / Q000276:immunology*; D006439:Hemodynamics; D018836:Inflammation Mediators / Q000378:metabolism; D008026:Ligation; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009200:Myocardial Contraction; D009206:Myocardium / Q000378:metabolism; D011677:Punctures
D000906:Antibodies; D016827:CD8 Antigens; D016207:Cytokines; D018836:Inflammation Mediators; D005677:G(M1) Ganglioside; C018835:asialo GM1 ganglioside